Anesderm, (25 mg + 25 mg)/g, cream
Prilocaine + Lidocaine
Anesderm contains two active substances - lidocaine and prilocaine. They belong to a group of medicines called local anesthetics.
The action of Anesderm is to temporarily eliminate the sensation in the superficial layers of the skin.
The cream is applied to the skin before certain medical procedures. This helps to eliminate pain in the skin; however, the patient may still feel pressure and touch.
Anesderm can be used to anesthetize the skin before:
Anesderm can also be used:
to anesthetize the genital area before:
Anesderm can also be used to anesthetize the skin before:
Before starting to use Anesderm, you should discuss it with your doctor or pharmacist.
Due to the possibility of increased absorption from freshly shaved skin, it is essential to follow the recommended dosage, area of application, and time of application on the skin.
Anesderm should be kept away from the eyes, as it may cause irritation.
If the cream accidentally gets into the eye, it should be rinsed immediately with lukewarm water or a physiological saline solution (0.9% NaCl solution). Caution should be exercised to avoid getting anything into the eye until sensation returns.
Anesderm should not be used on a diseased eardrum.
When Anesderm is used in a patient before administering a live vaccine (e.g., tuberculosis vaccine), it should be remembered to report for a follow-up visit at the time specified by the doctor to assess the effectiveness of the vaccination.
In infants/newborns under 3 months of age, a transient, clinically insignificant increase in methemoglobin concentration in the blood is commonly observed within 12 hours after using Anesderm.
The efficacy of Anesderm during blood sampling from the heel in newborns or to ensure adequate pain relief during circumcision has not been confirmed in clinical trials.
Anesderm should not be used on the skin of the genital organs (e.g., penis) and mucous membranes of the genital organs (e.g., vagina) in children (under 12 years of age) due to insufficient data on the absorption of active substances.
Anesderm should not be used in children under 12 months of age who are being treated with other medicines that affect blood pigments and may cause methemoglobinemia (e.g., sulfonamides; see also section 2 "Anesderm and other medicines").
Anesderm should not be used in premature newborns.
The patient should inform their doctor or pharmacist about any other medicines they are currently taking or have recently taken or may take. This includes medicines that can be bought without a prescription and herbal medicines. This is important because the ingredients of Anesderm may affect the action of some other medicines, and some other medicines may affect the action of Anesderm.
In particular, the patient should inform their doctor, pharmacist, or nurse if they have used or taken any of the following medicines:
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Occasional use of Anesderm during pregnancy is not associated with any risk of adverse effects on the fetus.
The active substances of Anesderm (lidocaine and prilocaine) pass into breast milk. However, the amount that passes into milk is so small that there is essentially no risk to the breastfed child.
In animal studies, no fertility disorders were found in males or females treated with the active ingredients of Anesderm.
Anesderm has no or negligible influence on the ability to drive and use machines when used as recommended.
Anesderm contains macrogolglycerol hydroxystearate 40, which may cause skin reactions.
Anesderm should always be used as recommended by the doctor or pharmacist. In case of doubts, the patient should consult their doctor, pharmacist, or nurse.
People who frequently apply or remove the cream from the patient's body should ensure that they effectively avoid contact with the cream to prevent the development of hypersensitivity.
The protective membrane of the tube is pierced using the tube cap.
When applying the Anesderm cream, it is essential to follow the instructions carefully:
Squeeze out a portion of cream from the tube to form a mound
in the place where it is needed on the skin
(e.g., where the injection will be made).
A line of cream about 3.5 cm long from the 30 g tube
corresponds to 1 g of cream. Half of the contents of the 5 g tube
corresponds to about 2 g of Anesderm cream.
Do not rub the cream into the skin.
Remove the paper layer from the dressing.
Remove the dressing covers. Then, carefully place
the dressing over the cream mound.
Do not spread the cream under the dressing.
Remove the plastic stiffener.
Carefully smooth the edges of the dressing.
Then, leave the dressing on for at least 60 minutes.
The doctor or nurse will remove the dressing and remove the cream before performing the medical procedure (e.g., before injecting a needle).
Usually, the dose of Anesderm used is 1 g of cream per 10 cm² (10 square centimeters) of skin surface, applied for 1 to 5 hours under a dressing. Anesderm should not be used on an area of freshly shaved skin larger than 600 cm² (600 square centimeters, e.g., 30 cm x 20 cm). The maximum dose is 60 g.
on the genital skin before minor surgical procedures on the skin (such as removal of warts)
In case of using a larger amount of Anesderm than recommended by the doctor, pharmacist, or nurse, the patient should contact them immediately, even if they do not feel any discomfort.
Symptoms that may occur after using too much Anesderm are listed below. These discomforts should not occur after using Anesderm as recommended.
In severe cases of overdose, symptoms such as seizures, decreased blood pressure, decreased breathing rate, respiratory arrest, and abnormal heart rhythm may occur. These symptoms can be life-threatening.
In case of any further doubts about the use of this medicine, the patient should consult their doctor, pharmacist, or nurse.
Like all medicines, Anesderm can cause side effects, although not everybody gets them.
In case of occurrence or persistence of any of the following side effects in the patient, the patient should contact their doctor or pharmacist. The patient should tell their doctor about anything that makes them feel unwell while using Anesderm.
At the site of application of Anesderm, a mild reaction may occur (paling or reddening of the skin, slight swelling, initial burning or itching sensation). These are common reactions to the cream and anesthetics, which disappear after a short time without the need for any medical intervention.
In case of occurrence of any worrying side effects in the patient while using Anesderm, the patient should stop using it and contact their doctor or pharmacist as soon as possible.
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Methemoglobinemia, a blood disorder, which is more frequently observed in children, often in connection with overdose in newborns and infants from 0 to 12 months.
If side effects occur, including any not listed in the leaflet, the patient should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: +48 22 49 21 301
fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Anesderm should not be used after the expiry date stated on the tube and carton packaging after "Expiry Date (EXP)". The expiry date refers to the last day of the specified month.
There are no special precautions for storage of the medicinal product.
The shelf life after opening the tube is 1 month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
It is a smooth, white cream.
Packaging size: 1 tube of 5 g + 2 adhesive dressings in a cardboard box
5 tubes of 5 g + 10 adhesive dressings in a cardboard box
1 tube of 30 g in a cardboard box
Not all packaging sizes may be available.
Pierre Fabre Medicament
Les Cauquillous
81500 Lavaur
France
Pierre Fabre Médicament Production
Établissement Progipharm,
Rue de Lycée
F-45500 Gien,
France
Germany: ANESDERM 25 mg/g + 25 mg/g Creme
Italy: ANESDERM 25 mg/g + 25 mg/g Crema
Poland: ANESDERM
Date of last revision of the leaflet:03/2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.